Seeing the Unseen: How Quantitative PET Unlocks Hidden Coronary Risk (2026)
Description

Discover how quantitative PET Myocardial Perfusion Imaging (MPI) identifies microvascular disease and diffuse atherosclerosis that often goes undetected by other imaging modalities or angiography. During this one-hour webinar, Dr. DiCarli will demonstrate the prognostic value of quantitative measurements from cardiac PET MPI and shows how to integrate them into risk stratification for coronary artery disease (CAD).

Through real-world clinical scenarios—patients with diabetes, non-obstructive CAD and persistent angina post-revascularization—you’ll see how cardiac PET drives diagnosis and management in complex cases. The discussion connects these insights to current guidelines for ischemia assessment and risk stratification from the American College of Cardiology, American Heart Association and American Society of Nuclear Cardiology.

Faculty

Marcelo DiCarli, MD
Professor of Radiology, Harvard Medical School
Chief, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; Executive Director, Cardiovascular Imaging Program, Departments of Radiology and Medicine, Brigham and Women's Hospital

Marcelo F. DiCarli, MD, is a professor at Harvard Medical School, chief of nuclear medicine and molecular imaging, and executive director of the cardiovascular imaging program at Brigham and Women’s Hospital. Trained in Argentina and at the University of California, Los Angeles, Dr. DiCarli has authored over 200 publications and edited major imaging texts. A thought leader in cardiovascular imaging—especially PET/CT and molecular techniques—he has held top leadership roles at the Society of Nuclear Medicine and Molecular Imaging, American Society of Nuclear Cardiology and American College of Cardiology. Dr. DiCarli currently serves as editor-in-chief of the Journal of Nuclear Cardiology and his research centers on ischemic heart disease, microvascular dysfunction and heart failure.

Course Overview

Sponsored by:




Discover how quantitative PET Myocardial Perfusion Imaging (MPI) identifies microvascular disease and diffuse atherosclerosis that often goes undetected by other imaging modalities or angiography. During this one-hour webinar, Dr. DiCarli will demonstrate the prognostic value of quantitative measurements from cardiac PET MPI and shows how to integrate them into risk stratification for coronary artery disease (CAD).

Through real-world clinical scenarios—patients with diabetes, non-obstructive CAD and persistent angina post-revascularization—you’ll see how cardiac PET drives diagnosis and management in complex cases. The discussion connects these insights to current guidelines for ischemia assessment and risk stratification from the American College of Cardiology, American Heart Association and American Society of Nuclear Cardiology.

Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:

  • Cardiac Radiology

Learning Objectives:

  • Discuss the evolution of coronary artery disease.
  • Discuss the use of cardiac PET MPI to diagnosis microvascular and diffuse CAD.
  • Discuss the use of quantitative measurements for prognosis and risk stratification of complex CAD.

This non-CME Other activity (live and enduring material) is estimated to take 1 hour to complete.

Start Date: 3/10/2026
Online Expiration Date: 3/9/2027

This educational activity was originally presented on 3/10/2026 as an interactive online webinar.

Faculty:

  • Marcelo DiCarli, MD

Price:
Non-Member/Basic Member Rate: $0.00
Standard Member/Full Access Member Rate: $0.00

Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.

RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events. Courses are best viewed on a desktop computer.

Summary
Availability:
Registration ends on March 10, 2026
Expires on Mar 09, 2027
Location:
Online Meeting
Date / Time:
Mar 10, 2026 12:00 PM - 1:00 PM CT
Cost:
FREE
Credit Offered:
No Credit Offered